← ResMed
What podcasts say about ResMed
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about ResMed
2 statements · 1 negative · 1 mixed
Chinese competitors selling similar devices at half price threaten ResMed.
“The main issue for us is that The devices they make, well, there's some Chinese competitors that make very similar looking devices that seem to do pretty much the same and they sell them for half the price. So I'm very worried about Chinese manufacturing competition”
Open the episode · Riding the rebound in CSL, Cochlear and finding the next opportunityListen at 24:49
ResMed remains a long-term compounder despite weak market sentiment.
“it's a continued compounder ResMed, but the market seems out of love with it still.”
Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael BurryListen at 10:32
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.